Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial

BACKGROUND: Long-term antithyroid drug therapy has become one of the options for treatment of Graves’ hyperthyroidism. The aim of this study was to compare thyroid status in those who discontinued methimazole (MMI) treatment after 12.8 years with those who continued MMI as long as 24 years. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Azizi, Fereidoun, Abdi, Hengameh, Amouzegar, Atieh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807686/
https://www.ncbi.nlm.nih.gov/pubmed/33446181
http://dx.doi.org/10.1186/s12902-020-00670-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7807686/
https://www.ncbi.nlm.nih.gov/pubmed/33446181
http://dx.doi.org/10.1186/s12902-020-00670-w

Ejemplares similares